SOURCE: Pipex Pharmaceuticals, Inc.

August 12, 2008 08:27 ET

Pipex Pharmaceuticals to Present at the Noble Financial Equity Conference

Noble Financial M.A.D. MAX Equity Conference

ANN ARBOR, MI--(Marketwire - August 12, 2008) - Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system and autoimmune diseases, announces that it will present at the Fourth Annual Noble Financial Equity Conference at 3:00 p.m. (Pacific) on Monday, August 18, 2008 at the Loews Lake Las Vegas Resort, Nevada. Mr. Nicholas Stergis, Chief Executive Officer of Pipex will discuss the Company's business strategy and provide an update on its product pipeline.

Mr. Stergis will give a 23-minute presentation regarding Pipex' market positioning, financial performance, and strategic direction. The presentation will be webcast LIVE featuring high-definition, streaming video and PowerPoint slides. Access is available by logging on to the conference website www.noblemadmax.com or by going to our website at www.pipexinc.com. It is recommended that interested parties register at least 15 minutes prior to the start of the presentation to ensure timely access.

About Pipex Pharmaceuticals, Inc.

Pipex Pharmaceuticals, Inc. is a specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of central nervous system and autoimmune diseases. Pipex's strategy is to exclusively in-license proprietary, clinical-stage drug candidates and to complete the further clinical testing, manufacturing and regulatory requirements and seek marketing authorizations. Pipex is focused on treating Dry Age-Related Macular Degeneration (AMD), multiple sclerosis (MS), and fibromyalgia. For further information, please visit www.pipexinc.com.

About Noble Financial

Noble Financial is a privately held, full-service capital markets firm driven by what is often overlooked by other firms -- uncovering the value embedded in the orphaned, undiscovered or misunderstood company. The company focuses on converting market inefficiencies into profit opportunities. Noble Financial supports emerging companies through strategic advice, investment banking, market-making, sales & trading, comprehensive equity research, and the development of institutional support. Noble Financial's equity conferences -- 2008 marks their fourth annual -- allow for a unique blend of professional and personal interaction among a diverse cross-section of executives. The company has operated for 24 years and has offices in Florida, New York City and Boston.

Contact Information

  • For Further Information Contact:

    Nicholas Stergis
    Chief Executive Officer
    (734) 332-7800

    Redington, Inc. (Investor Relations)
    Thomas Redington
    203-222-7399
    www.redingtoninc.com